Generation of reassortant influenza vaccines by reverse genetics that allows utilization of a DIVA (Differentiating Infected from Vaccinated Animals) strategy for the control of avian influenza

Vaccine

Volumn 22, Issue 23-24, 2004, Pages 3175-3181

  Lee, Chang Won ^a   Senne, Dennis A ^b   Suarez, David L ^a  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

^b National Veterinary Services Laboratories   (United States)

Author keywords

Avian influenza; DIVA strategy; Reverse genetics

Indexed keywords

HEMAGGLUTINATION INHIBITING ANTIBODY; INACTIVATED VACCINE; INFLUENZA VACCINE; SIALIDASE;

ANIMAL EXPERIMENT; ANTIBODY DETECTION; ARTICLE; AVIAN INFLUENZA; BIRD DISEASE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME INHIBITION; EXPERIMENTAL INFECTION; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC REASSORTMENT; HEMAGGLUTINATION INHIBITION TEST; IMMUNOFLUORESCENCE TEST; INFECTION CONTROL; INFLUENZA; INFLUENZA VACCINATION; NONHUMAN; PRIORITY JOURNAL; SPECIES DIFFERENTIATION;

ANIMALS; ANTIBODIES, VIRAL; CHICKENS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; INFLUENZA A VIRUS; INFLUENZA IN BIRDS; INFLUENZA VACCINES; PLASMIDS; POULTRY DISEASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VACCINATION; VACCINES, DNA;

EID: 3843071042     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.01.055     Document Type: Article

References (32)

1. Swayne DE, Halvorson DA. Influenza. In: Saif YM, Barnes HJ, Glisson JR, Fadly AM, McDougald LR, Swayne DE, editors. Diseases of poultry. Ames, Iowa: Iowa State University Press; 2003. p. 135-60.
2. Halvorson D.A. The control of H5 or H7 mildly pathogenic avian influenza: a role for inactivated vaccine. Avian. Pathol. 31:2002;5-12
3. Crawford J., Wilkinson B., Vosnesensky A., et al. Baculovirus-derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes. Vaccines. 17:1999;2265-2274
4. Kodihalli S., Haynes J.R., Robinson H.L., Webster R.G. Cross-protection among lethal H5N2 influenza viruses induced by DNA vaccine to the hemagglutinin. J. Virol. 71:1997;3391-3396
5. Castellan DM. Low pathogenic H6N2 avian influenza in California. In: Frame D, editor. Proceedings of the 52nd western poultry disease conference. Sacramento, California; 2003. p. 1-2.
6. Villarreal-Chavez CL, Flores AO. The Mexican avian influenza (H5N2) outbreak. In: Swayne DE, Slemons RD, editors. Proceedings of the fourth international symposium on avian influenza. Richmond, Virginia: US Animal Health Association; 1998. p. 18-22.
7. Naeem K. The avian influenza H7N3 outbreak in South Central Asia. In: Swayne DE, Slemons RD, editors. Proceedings of the fourth international symposium on avian influenza. Richmond, Virginia: US Animal Health Association; 1998. p. 31-5.
8. Swayne D.E., Beck J.R., Kinney N. Failure of a recombinant fowl poxvirus vaccine containing an avian influenza hemagglutinin gene to provide consistent protection against influenza in chickens preimmunized with a fowl pox vaccine. Avian Dis. 44:2000;132-137
9. Beard CW. To vaccinate or not to vaccinate. In: Beard CW, Easterday BC, editors. Proceedings of the second international symposium on avian influenza. Richmond, Virginia: US Animal Health Association; 1986. p. 258-63.
10. Stone H.D. Efficacy of avian influenza oil-emulsion vaccines in chickens of various ages. Avian Dis. 31:1987;483-490
11. Capua I., Terregino C., Cattoli G., Mutinelli F., Rodriguez J.F. Development of a DIVA (Differentiating Infected from Vaccinated Animals) strategy using a vaccine containing a heterologous neuraminidase for the control of avian influenza. Avian Pathol. 32:2003;47-55
12. Capua I., Marangon S., Cordioli P., Bonfanti L., Santucci U. H7N3 avian influenza in Italy. Vet. Rec. 151:2002;743-744
13. Swayne D.E., Garcia M., Beck J.R., Kinney N., Suarez D.L. Protection against diverse highly pathogenic H5 avian influenza viruses in chickens immunized with a recombinant fowlpox vaccine containing an H5 avian influenza hemagglutinin gene insert. Vaccine. 18:2000;1088-1095
14. Horimoto T., Kawaoka Y. Molecular changes in virulent mutants arising from avirulent avian influenza viruses during replication in 14-day-old embryonated eggs. Virology. 206:1995;755-759
15. Lee CW, Senne DA, Linares JA, et al. Characterization of recent H5 subtype avian influenza viruses from U.S. poultry. Avian Pathol (in press).
16. Spackman E., Senne D.A., Davison S., Suarez D.L. Sequence analysis of recent H7 avian influenza viruses associated with three different outbreaks in commercial poultry in the United States. J. Virol. 77:2003;13399-13402
17. Tumpey T.M., Suarez D.L., Perkins L.E., et al. Characterization of a highly pathogenic H5N1 avian influenza A virus isolated from duck meat. J. Virol. 76:2002;6344-6355
18. Suarez D.L., Perdue M.L., Cox N., et al. Comparisons of highly virulent H5N1 influenza A viruses isolated from humans and chickens from Hong Kong. J. Virol. 72:1998;6678-6688
19. Neumann G., Watanabe T., Ito H., et al. Generation of influenza A viruses entirely from cloned cDNAs. Proc. Natl. Acad. Sci. U.S.A. 96:1999;9345-9350
20. Stone H., Mitchell B., Brugh M. In ovo vaccination of chicken embryos with experimental Newcastle disease and avian influenza oil-emulsion vaccines. Avian Dis. 41:1997;856-863
21. Spackman E., Senne D.A., Myers T.J., et al. Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes. J. Clin. Microbiol. 40:2002;3256-3260
22. Van Deusen R.A., Hinshaw V.S., Senne D.A., Pellacani D. Micro neuraminidase-inhibition assay for classification of influenza A virus neuraminidases. Avian Dis. 27:1983;745-750
23. Tumpey TM, Kapczynski DR, Swayne DE. Comparative susceptibility of chickens and turkeys to avian influenza A H7N2 virus infection and protective efficacy of a commercial avian influenza H7N2 virus vaccine. Avian Dis (in press).
24. Hoffmann E., Krauss S., Perez D., Webby R., Webster R.G. Eight-plasmid system for rapid generation of influenza virus vaccines. Vaccine. 20:2002;3165-3170
25. Brugh M., Beard C.W., Stone H.D. Immunization of chickens and turkeys against avian influenza with monovalent and polyvalent oil emulsion vaccines. Am. J. Vet. Res. 40:1979;165-169
26. Swayne DE, Senne DA, Beard CW. Influenza. In: Swayne DE, Glisson JR, Jackwood MW, Pearson JE, Reed WM, editors. Isolation and identification of avian pathogens. Kennett Square, Pennsylvania: American Association of Avian Pathologists; 1998. p. 150-5.
27. Panigrahy B., Senne D.A., Pedersen J.C. Avian influenza virus subtypes inside and outside the live bird markets, 1993-2000: a spatial and temporal relationship. Avian Dis. 46:2002;298-307
28. Pomeroy BS. Report of the subcommittee on avian influenza. In: Proceedings of the 99th annual meeting of the united states animal health association. Reno, Nevada: U.S. Animal Health Association; 1995. p. 569-78.
29. Swayne DE. Avian influenza vaccine used during 2001. In: Proceedings of the 104th annual meeting of the United States animal health association. Richmond, Virginia: U.S. Animal Health Association; 2001. p. 469-71.
30. Kilbourne E.D. Future influenza vaccines and the use of genetic recombinants. Bull World Health Organ. 41:1969;643-645
31. Swayne D.E., Perdue M.L., Beck J.R., Garcia M., Suarez D.L. Vaccines protect chickens against H5 highly pathogenic avian influenza in the face of genetic changes in field viruses over multiple years. Vet. Microbiol. 74:2000;165-172
32. Hinshaw V.S., Sheerar M.G., Larsen D. Specific antibody responses and generation of antigenic variants in chickens immunized against a virulent avian influenza virus. Avian Dis. 34:1990;80-86